RNS Number : 5697U
EKF Diagnostics Holdings PLC
08 April 2016
 

 

EKF Diagnostics Holdings plc
("EKF" or the "Company")

 

Directorate Change

 

EKF Diagnostics Holdings plc (AIM: EKF), the point-of-care business, announces that Christopher Mills has been appointed as Non-Executive Chairman with immediate effect.

 

Christopher is Chief Executive and the sole shareholder of Harwood Capital Management Limited and founder of JO Hambro. He is a fund manager of Oryx International Growth Fund Limited and North Atlantic Smaller Companies Investment Trust PLC and has been and continues to serve as a director of many public and private companies.

 

Christopher Harwood Bernard Mills, aged 63, is interested in 81,200,000 ordinary shares, being 19.24 per cent. of the Company's issued share capital. 46,200,000 ordinary shares are held by North Atlantic Smaller Companies Investment Trust PLC and 35,000,000 ordinary shares are held by Oryx International Growth Fund Limited. Harwood Capital LLP is investment manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Harwood Capital LLP is a limited liability partnership of which Christopher Mills is a partner and Chief Investment Officer.

 

A further announcement containing the disclosures in accordance with the AIM Rules will be made in due course.

 

 

EKF Diagnostics Holdings plc     

Tel: 029 2071 0570

Julian Baines, CEO

Mob: 07788 420 859

 

 

Panmure Gordon (UK) Limited

Tel: 020 7886 2500

Robert Naylor (Corporate Finance)

 

Paul Fincham (Corporate Finance)

 

 

 

Walbrook PR Limited 

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

       

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUCPCUPQPUM
admin Directorate Change 24233209 A Fri, 04/08/2016 - 07:00 Executive Changes EKF